Ads
related to: S%26P Futures
Search results
Melius sees brighter future for cruise liner stocks By Investing.com
Investing.com· 6 hours agoThe firm pointed out that despite previous challenges, cruise liners are poised for a positive shift...
Stock market today: Asian shares track Wall Street's slide on worries over interest rates
ABC News· 5 days agoAsian shares were mostly lower Friday after Wall Street retreated following strong economic reports...
Tuesday's analyst calls: Cruise stock gets an upgrade, regional bank to rally 30%
CNBC· 7 hours agoMeanwhile, JPMorgan upgraded Huntington Bancshares to overweight from neutral, with a price target...
Why You Should Bet on 5 Top-Ranked Stocks With Rising P/E
Zacks via Yahoo Finance· 5 hours agoTap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These are Vita...
Stock market today: Asian shares are mixed after US holiday quiet
ABC News· 13 hours agoChinese markets rose after senior leaders of the ruling Communist Party met and affirmed Beijing’s...
Intel Corp. (INTC) Forecast: Revisiting The Past To Gain Insights For The Future – Stocks Register
Stocks Register· 5 days ago:INTC) concluded the trading at $31.42 on Wednesday, May 22, with a fall of -1.01% from its closing price on previous day. Taking a look at stock we notice that its last check on previous day ...
UBS reaffirms Fluence Energy shares target, cites demand from AI data centers By Investing.com
Investing.com· 4 hours agoTuesday, UBS reaffirmed its Buy rating on Fluence Energy Inc. (NASDAQ:FLNC), with a steady price...
Jim Cramer's top 10 things to watch in the stock market Wednesday
CNBC· 6 days agoMy top 10 things to watch Wednesday, May 22 Nvidia earnings day. Stock futures are slightly lower...
PDF Solutions share price target raised by DA Davidson on demand acceleration By Investing.com
Investing.com· 4 hours agoTuesday, on Wall Street, PDF Solutions Inc. (NASDAQ:PDFS) saw its share price target increased by DA...
Insmed shares rise on positive phase 3 trial results By Investing.com
Investing.com· 5 hours agoThe data, which supports a potential $2.5 billion commercial opportunity in non-cystic fibrosis...
